| Bayer (Schweiz) AG - Eylea 8 mg/0.07ml, Injektionslösung in einer Fertigspritze |
| 62393 | | 02 | | Eylea 8 mg/0.07ml | | Injektionslösung in einer Fertigspritze | | S01LA05 | | Aflibercept | | 04.02.2025 | | |
|
| Composition |
| afliberceptum 8 mg, arginini hydrochloridum, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.07 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Afliberceptum | 8mg / 0.07ml |
| | BAG: Active Agent | Dose |
|---|
| Afliberceptum | 8 mg |
| | | | Inactive agents |
|---|
| Arginine Hydrochloride | | Histidin Hydrochloride Monohydrate | | Histidine | | Polysorbatum 20 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | | 845.90 | 936.40 | B | SL | No |
|
